Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ammara Naveed"'
Autor:
Sara Rizvi Jafree, Ammara Naveed, Humna Ahsan, Syeda Khadija Burhan, Masha Asad Khan, Amna Khawar, Florian Fischer
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Chronic liver disease (CLD) is one of the leading disease burdens in Pakistan. Until now, there has only been limited focus in the country on providing health services through tertiary services in urban cities, whereas there is al
Externí odkaz:
https://doaj.org/article/f02c713debe641848f73270c2b4c8cf5
Publikováno v:
Gut and Liver, Vol 16, Iss 3, Pp 489-492 (2022)
A pyloric gland adenoma is a rare neoplasm that occurs most frequently in the stomach and should be removed because of its precancerous potential. Although there have been case reports of pyloric gland adenomas in extragastric areas such as the duode
Externí odkaz:
https://doaj.org/article/8f8674e2c2c842eb97628de193889d58
Autor:
Aaron G Lim, DPhil, Josephine G Walker, PhD, Nyashadzaishe Mafirakureva, PhD, Gul Ghuttai Khalid, MPH, Huma Qureshi, FRCP, Hassan Mahmood, FRSPH, Adam Trickey, PhD, Hannah Fraser, PhD, Khawar Aslam, MBBS, Gregoire Falq, MPH, Camille Fortas, MPH, Hassaan Zahid, MBBS, Ammara Naveed, MBBS, Rosa Auat, MD, Quaid Saeed, MPH, Charlotte F Davies, PhD, Christinah Mukandavire, PhD, Nancy Glass, MPH, David Maman, MD, Natasha K Martin, DPhil, Matthew Hickman, ProfPhD, Margaret T May, ProfPhD, Saeed Hamid, ProfFRCP, Anne Loarec, MD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publikováno v:
The Lancet Global Health, Vol 8, Iss 3, Pp e440-e450 (2020)
Summary: Background: The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global hepatitis C incidence by 80% by 2030, but little is known about how this reduction could be achieved and the costs o
Externí odkaz:
https://doaj.org/article/52e9e7abd86245788c40fc6ac95606e9
Publikováno v:
Gastroenterology Research and Practice, Vol 2014 (2014)
Introduction. Large volume paracentesis is considered a safe procedure carrying minimal risk of complications and rarely causing morbidity or mortality. The most common complications of the procedure are ascitic fluid leakage, hemorrhage, infection,
Externí odkaz:
https://doaj.org/article/ac1713849d874e75a7c7a1123b2574f6
Autor:
Sara Rizvi Jafree, Ammara Naveed, Humna Ahsan, Syeda Khadija Burhan, Amna Khawar, Masha Asad Khan, Florian Fischer
Background Pakistan has one of the highest rates of chronic liver disease (CLD) burden in the world. Poor and underserved patients of CLD in the country may suffer from limited health-seeking behaviors, but there is not much research in this area. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::082530ec59c2d632b4768fb355673188
https://doi.org/10.21203/rs.3.rs-2911961/v1
https://doi.org/10.21203/rs.3.rs-2911961/v1
Publikováno v:
SSRN Electronic Journal.
Autor:
Wadih Chacra, Sean Koppe, Lisa Landers, Adam E. Mikolajczyk, Ammara Naveed, Christine Chan, David K. Choi, Michelle T. Martin
Publikováno v:
International Journal of Clinical Pharmacy. 43:753-755
Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatm
Autor:
Faheem, Khan, Ammara, Naveed
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 71(5)
Autor:
Nyashadzaishe Mafirakureva, Hassan Mahmood, Camille Fortas, Natasha K. Martin, Gregoire Falq, Quaid Saeed, Josephine G. Walker, Matthew Hickman, Gul Ghuttai Khalid, David Maman, Rosa Auat, Adam Trickey, Aaron G Lim, Anne Loarec, Ammara Naveed, Hannah Fraser, Peter Vickerman, Saeed Hamid, Huma Qureshi, Christinah Mukandavire, Khawar Aslam, Francisco Averhoff, Margaret T May, Hassaan Zahid, Nancy Glass, Charlotte F Davies
Publikováno v:
Lancet Glob Health
The Lancet Global Health, Vol 8, Iss 3, Pp e440-e450 (2020)
The Lancet Global Health
Lim, A G, Walker, J G, Mafirakureva, N, Khalid, G G, Qureshi, H, Mahmood, H, Trickey, A, Fraser, H, Aslam, K, Falq, G, Fortas, C, Zahid, H, Naveed, A, Auat, R, Saeed, Q, Davies, C F, Mukandavire, C, Glass, N, Maman, D, Martin, N K, Hickman, M, May, M T, Hamid, S, Loarec, A, Averhoff, F & Vickerman, P 2020, ' Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan : a modelling analysis ', Lancet Global Health, vol. 8, no. 3, pp. e440-e450 . https://doi.org/10.1016/S2214-109X(20)30003-6
Lim, A G, Walker, J G, Mafirakureva, N, Khalid, G G, Qureshi, H, Mahmood, H, Trickey, A, Fraser, H, Aslam, K, Falq, G, Fortas, C, Zahid, H, Naveed, A, Auat, R, Saeed, Q, Davies, C F, Mukandavire, C, Glass, N, Maman, D, Martin, N, Hickman, M, May, M T, Hamid, S, Loarec, A, Averhoff, F & Vickerman, P 2020, ' Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan : a modelling analysis ', Lancet Global Health, vol. 8, no. 3, pp. e440-e450 . https://doi.org/10.1016/S2214-109X(20)30003-6
The Lancet Global Health, Vol 8, Iss 3, Pp e440-e450 (2020)
The Lancet Global Health
Lim, A G, Walker, J G, Mafirakureva, N, Khalid, G G, Qureshi, H, Mahmood, H, Trickey, A, Fraser, H, Aslam, K, Falq, G, Fortas, C, Zahid, H, Naveed, A, Auat, R, Saeed, Q, Davies, C F, Mukandavire, C, Glass, N, Maman, D, Martin, N K, Hickman, M, May, M T, Hamid, S, Loarec, A, Averhoff, F & Vickerman, P 2020, ' Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan : a modelling analysis ', Lancet Global Health, vol. 8, no. 3, pp. e440-e450 . https://doi.org/10.1016/S2214-109X(20)30003-6
Lim, A G, Walker, J G, Mafirakureva, N, Khalid, G G, Qureshi, H, Mahmood, H, Trickey, A, Fraser, H, Aslam, K, Falq, G, Fortas, C, Zahid, H, Naveed, A, Auat, R, Saeed, Q, Davies, C F, Mukandavire, C, Glass, N, Maman, D, Martin, N, Hickman, M, May, M T, Hamid, S, Loarec, A, Averhoff, F & Vickerman, P 2020, ' Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan : a modelling analysis ', Lancet Global Health, vol. 8, no. 3, pp. e440-e450 . https://doi.org/10.1016/S2214-109X(20)30003-6
Background\ud The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global hepatitis C incidence by 80% by 2030, but little is known about how this reduction could be achieved and the costs of doing